CBD reduced the motivation to self-administer methamphetamine and lessened the relapse of methamphetamine-seeking behaviors.
Once completed, the study will provide the first available high quality data on the safety of CBD extract to treat pediatric patients with drug resistant epilepsies.
The study concentrated on a twenty question online survey to examine dermatologists' knowledge, attitude and perception of therapeutic CBD.
This study suggests that CBD administered to middle-aged rats with CCH aids in the reduction of neuroinflammation and the enhancement of memory performance.
By looking at these studies as a whole the researchers stated with moderate certainty that CBD reduces seizures among children with drug-resistant epilepsy.
Epidolex is the first cannabis and cannabidiol (CBD)-based drug approved by the FDA and specifically treats Lennox-Gastaut syndrome and Dravet syndrome.
CBD Administered During Peri-Adolescence Prevents Behavioral Abnormalities in Rats with an Animal Model of Schizophrenia
This study aimed to help prevent the emergence of schizophrenia in peri-adolescence by administering CBD to rats with an animal model of schizophrenia.